(Q30538692)

16 August 2017

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study (English)

1 reference

16 August 2017

1 reference

0 references

Gregory Petyt

7

0 references

Susanna Schraen

Susanna Schraen

11

0 references

Arnaud Delval

Arnaud Delval

2

0 references

David Blum

David Blum

9

0 references

David Devos

David Devos

15

0 references

Luc Defebvre

4

Luc Defebvre

1 reference

16 August 2017

Caroline Moreau

1

1 reference

16 August 2017

Vincent Tiffreau

3

1 reference

16 August 2017

Kathy Dujardin

5

1 reference

16 August 2017

Alain Duhamel

6

1 reference

16 August 2017

Claude Hossein-Foucher

8

1 reference

16 August 2017

Bernard Sablonnière

10

1 reference

16 August 2017

Delphine Allorge

12

1 reference

16 August 2017

Alain Destée

13

1 reference

16 August 2017

Régis Bordet

14

1 reference

16 August 2017

language of work or name

English

0 references

publication date

16 October 2012

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

16 August 2017

1 reference

16 August 2017

84

1 reference

16 August 2017

5

1 reference

16 August 2017

552-555

1 reference

Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Mechanism of action of memantine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Prospective assessment of falls in Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

The pedunculopontine nucleus and Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Effects of intravenous administration of memantine in parkinsonian patients (author's transl)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Effects of ibotenate pedunculopontine tegmental nucleus lesions on exploratory behaviour in the open field

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Effect of glutamate and antagonists of N-methyl-D-aspartate receptors on experimental parkinsonian syndrome in rats.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3623038

Trunk muscle strength, but not trunk rigidity, is independently associated with bone mineral density of the lumbar spine in patients with Parkinson's disease

26 November 2018

1 reference

12 December 2020

[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]

1 reference

12 December 2020

Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP-2012-303182

1 reference

16 August 2017

1 reference

16 August 2017

1 reference